Hospira Appoints David Endicott As President, Hospira Medical Devices

(RTTNews) - Hospira Inc. (HSP) announced that it has appointed David Endicott as President, Hospira Medical Devices, effective March 10, 2014.

In this newly created role, Endicott will have responsibility for establishing a fully integrated device organization - leading the commercial, research and development, manufacturing and related support functions to continue to advance the company's product pipeline, execute its device strategy and ultimately drive global growth. He will serve as a member of Hospira's senior leadership team and report directly to Michael Ball, chief executive officer.

Most recently, Endicott, 49, served as President, Allergan Medical, Asia Pacific and Latin America and as an executive committee member of Allergan Inc. Prior to this position, he served as President, Europe, Africa and Middle East.